Whole-cell vaccines, which are suspensions of killed Bordetellapertussis organisms, are among our most effective and leastsatisfactory vaccines. Before immunization was routine, pertussiswas endemic in the United States, with up to 260,000 cases and9000 deaths per year.1 By 1976 there were only 1010 cases and7 deaths.1 Although the whole-cell vaccines have been effective,adverse effects are common. Worse still, pertussis vaccine hasbeen temporally associated with devastating events such as suddeninfant death. Although most careful studies suggest no causalrelation, the existing pertussis vaccines have remained a sourceof disquiet to physicians and parents alike.
Acellular Pertussis Vaccines
Poltera A. A., Tamburlini G., Materassi P., Decker M. D., Edwards K. M.
Extract |
Full Text
N Engl J Med 1996;
334:1547-1548, Jun 6, 1996.
Correspondence
This article has been cited by other articles:
Esposito, S., Agliardi, T., Giammanco, A., Faldella, G., Cascio, A., Bosis, S., Friscia, O., Clerici, M., Principi, N.
(2001). Long-Term Pertussis-Specific Immunity after Primary Vaccination with a Combined Diphtheria, Tetanus, Tricomponent Acellular Pertussis, and Hepatitis B Vaccine in Comparison with That after Natural Infection. Infect. Immun.
69: 4516-4520
[Abstract][Full Text]
Mollnes, T. E., Harboe, M.
(1996). Recent Advances: Clinical immunology. BMJ
312: 1465-1469
[Abstract][Full Text]
Poltera, A. A., Tamburlini, G., Materassi, P., Decker, M. D., Edwards, K. M.
(1996). Acellular Pertussis Vaccines. NEJM
334: 1547-1548
[Full Text]
(1996). ACELLULAR PERTUSSIS VACCINE: A NEW ERA FOR INFANTS. JWatch General
1996: 5-5
[Full Text]